Laboratoire de Chimie de Coordination UPR 8241


Accueil > EQUIPES > Equipe V

Publications

2022

Egwu, C. O., Pério, P., Augereau, J. - M., Tsamesidis, I., Benoit-Vical, F., & Reybier, K. (2022). Resistance to artemisinin in falciparum malaria parasites: A redox-mediated phenomenon. Free Radical Biol. Med., 179, 317–327.
Li, Y., Nguyen, M., Vendier, L., Robert, A., Liu, Y., & Meunier, B. (2022). X-Ray diffraction structure of Cu(II) and Zn(II) complexes of 8-aminoquinoline derivatives (TDMQ), related to the activity of these chelators as potential drugs against Alzheimer's disease. J. Mol. Struct., 1251, 132078/1–6.
Paloque, L., Coppée, R., Stokes, B. H., Gnädig, N. F., Niaré, K., Augereau, J. - M., Fidock, D. A., Clain, J., & Benoit-Vical, F. (2022). Mutation in the Plasmodium falciparum BTB/POZ domain of K13 protein confers artemisinin resistance. Antimicrob. Agents Chemother., 66(1), e01320–21.
Tsamesidis, I., Mousavizadeh, F., Egwu, C. O., Amanatidou, D., Pantaleo, A., Benoit-Vical, F., Reybier, K., & Giannis, A. (2022). In vitro and in silico antimalarial evaluation of FM-AZ, a new artemisinin derivative. Medicines, 9(2), 8/1–12.

2021

Amrane, D., Arnold, C. - S., Hutter, S., Sanz-Serrano, J., Collia, M., Azqueta, A., Paloque, L., Cohen, A., Amanzougaghene, N., Tajeri, S., Franetich, J. - F., Mazier, D., Benoit-Vical, F., Verhaeghe, P., Azas, N., Vanelle, P., Botté, C., & Primas, N. (2021). 2-phenoxy-3-trichloromethylquinoxalines are antiplasmodial aerivatives with activity against the apicoplast of Plasmodium falciparum. Pharmaceuticals, 14(8), 724/1–24.
Bosson-Vanga, H., Primas, N., Franetich, J. - F., Lavazec, C., Gomez, L., Ashraf, K., Tefit, M., Soulard, V., Dereuddre-Bosquet, N., Le Grand, R., Donnette, M., Mustière, R., Amanzougaghene, N., Tajeri, S., Suzanne, P., Malzert-Fréon, A., Rault, S., Vanelle, P., Hutter, S., Cohen, A., Snounou, G., Roques, P., Azas, N., Lagardère, P., Lisowski, V., Masurier, N., Nguyen, M., Paloque, L., Benoit-Vical, F., Verhaeghe, P., et al. (2021). A new thienopyrimidinone chemotype shows multistage activity against Plasmodium falciparum, including artemisinin-resistant parasites. Microbiol. Spectrum, 9(2), e00274–21/1–19.
Egwu, C. O., Augereau, J. - M., Reybier, K., & Benoit-Vical, F. (2021). Reactive oxygen species as the brainbox in malaria treatment. Antioxidants, 10(12), 1872/1–20.
Egwu, C. O., Tsamesidis, I., Pério, P., Augereau, J. - M., Benoit-Vical, F., & Reybier, K. (2021). Superoxide: A major role in the mechanism of action of essential antimalarial drugs. Free Radical Biol. Med., 167, 271–275.
Gonnet, L., Baron, M., & Baltas, M. (2021). Synthesis of biologically relevant 1,2,3- and 1,3,4-triazoles: From classical pathway to green chemistry. Molecules, 26(18), 5667/1–27.
Gonnet, L., Chamayou, A., André-Barrès, C., Micheau, J. - C., Guidetti, B., Sato, T., Baron, M., Baltas, M., & Calvet, R. (2021). Elucidation of the Diels-Alder reaction kinetics between diphenylfulvene and maleimide by mechanochemistry and in solution. ACS Sustainable Chem. Eng., 9(12), 4453–4462.
Koumpoura, C. L., Robert, A., Athanassopoulos, C. M., & Baltas, M. (2021). Antimalarial inhibitors targeting epigenetics or mitochondria in Plasmodium falciparum: Recent survey upon synthesis and biological evaluation of potential drugs against malaria. Molecules, 26(18), 5711/1–34.
Ouji, M., Nguyen, M., Mustière, R., Jimenez, T., Augereau, J. - M., Benoit-Vical, F., & Deraeve, C. (2021). Novel molecule combinations and corresponding hybrids targeting artemisinin-resistant Plasmodium falciparum parasites. Bioorg. Med. Chem. Lett., 39, 127884/1–6.
Zhao, J., Shi, Q., Tian, H., Li, Y., Liu, Y., Xu, Z., Robert, A., Liu, Q., & Meunier, B. (2021). TDMQ20, a specific copper chelator, reduces memory impairments in Alzheimer’s disease mouse models. ACS Chem. Neurosci., 12(1), 140–149.
Zhao, J., Shi, Q., Tian, H., Li, Y., Liu, Y., Xu, Z., Robert, A., Liu, Q., & Meunier, B. (2021). TDMQ20, a specific copper chelator, reduces memory impairments in Alzheimer’s disease mouse models. ACS Chem. Neurosci., 12(1), 140–149.

2020

Cai, J., Dao, P., Chen, H., Yan, L., Li, Y. L., Zhang, W., Li, L., Du, Z., Dong, C. - Z., & Meunier, B. (2020). Ultrasmall superparamagnetic iron oxide nanoparticles-bound NIR dyes: Novel theranostic agents for Alzheimer's disease. Dyes Pigm., 173, 107968/1–8.
Laghchioua, F. E., Kouakou, A., Eddahmi, M., Viale, M., Monticone, M., Gangemi, R., Maric, I., El Ammari, L., Saadi, M., Baltas, M., Kandri Rodi, Y., & Rakib, E. M. (2020). Antiproliferative and apoptotic activity of new indazole derivatives as potential anticancer agents. Arch. Pharm., 353(12), 2000173/1–11.
Leygue, N., Galaup, C., Lopera, A., Delgado-Pinar, E., Williams, R. M., Gornitzka, H., Zwier, J. M., García-España, E., Lamarque, L., & Picard, C. (2020). Tripyridinophane platform containing three acetate pendant arms: An attractive structural entry for the development of neutral Eu(III) and Tb(III) complexes in aqueous solution. Inorg. Chem., 59(2), 1496–1512.
Meunier, B. (2020). Covid-19, ou quand le manque d’antiviraux efficaces devient un problème mondial. Actualité Chimique, 451, 1–5.
Meunier, B. (2020). Recherche thérapeutique et modèles animaux : faut-il supprimer l’expérimentation animale ? Actualité Chimique, 449, 55.
Nguyen, M., Ferji, K., Lecommandoux, S., & Bonduelle, C. (2020). Amphiphilic nucleobase-containing polypeptide copolymers--synthesis and self-assembly. Polymers, 12(6), 1357/1–13.